PT - JOURNAL ARTICLE AU - Kristin J. Cummings AU - John Beckman AU - Matthew Frederick AU - Robert Harrison AU - Alyssa Nguyen AU - Robert Snyder AU - Elena Chan AU - Kathryn Gibb AU - Andrea Rodriguez AU - Jessie Wong AU - Erin L. Murray AU - Seema Jain AU - Ximena Vergara TI - Disparities in COVID-19 Fatalities among Working Californians AID - 10.1101/2021.11.10.21266195 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.10.21266195 4099 - http://medrxiv.org/content/early/2021/11/11/2021.11.10.21266195.short 4100 - http://medrxiv.org/content/early/2021/11/11/2021.11.10.21266195.full AB - Background Information on the occupational distribution of COVID-19 mortality is limited.Objective To characterize COVID-19 fatalities among working Californians.Design Retrospective study of laboratory-confirmed COVID-19 fatalities with dates of death from January 1 to December 31, 2020.Setting California.Participants COVID-19 accounted for 8,050 (9.9%) of 81,468 fatalities among Californians 18-64 years old. Of these decedents, 2,486 (30.9%) were matched to state employment records and classified as “confirmed working.” The remainder were classified as “likely working” (n=4,121 [51.2%]) or “not working” (n=1,443 [17.9%]) using death certificate and case registry data.Measurements We calculated age-adjusted overall and occupation-specific COVID-19 mortality rates using 2019 American Community Survey denominators.Results Confirmed and likely working COVID-19 decedents were predominantly male (76.3%), Latino (68.7%), and foreign-born (59.6%), with high school or less education (67.9%); 7.8% were Black. The overall age-adjusted COVID-19 mortality rate was 30.0 per 100,000 workers (95% confidence interval [CI], 29.3-30.8). Workers in nine occupational groups had mortality rates higher than this overall rate, including those in farming (78.0; 95% CI, 68.7-88.2); material moving (77.8; 95% CI, 70.2-85.9); construction (62.4; 95% CI, 57.7-67.4); production (60.2; 95% CI, 55.7-65.0); and transportation (57.2; 95% CI, 52.2-62.5) occupations. While occupational differences in mortality were evident across demographic groups, mortality rates were three-fold higher for male compared with female workers and three- to seven-fold higher for Latino and Black workers compared with Asian and White workers.Limitations The requirement that fatalities be laboratory-confirmed and the use of 2019 denominator data may underestimate the occupational burden of COVID-19 mortality.Conclusion Californians in manual labor and in-person service occupations experienced disproportionate COVID-19 mortality, with the highest rates observed among male, Latino, and Black workers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the California Department of Public Health, with funding from the National Institute for Occupational Health and the Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The California Health and Human Services Agency Committee for the Protection of Human Subjects exempted the study from institutional review board review.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests for data should be communicated to the California Department of Public Health.